PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model

被引：0
|
作者：
Smith, Jenessa B. [1 ]
Codde, Rebecca [1 ]
Tan, Yening [1 ]
Barnett, Burton E. [1 ]
Hermanson, David [1 ]
Rengarajan, Srinivas [1 ]
Ostertag, Eric M. [1 ]
Shedlock, Devon J. [1 ]
机构：
[1] Poseida Therapeut, San Diego, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P490
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient
    Bernal-Estevez, David
    Sanchez, Ramiro
    Tejada, Rafael E.
    Parra-Lopez, Carlos
    BMC CANCER, 2016, 16
  • [42] Hybrid cell vaccination (tumor cell: dendritic cell) generates tumor specific immune response and increases survival in a murine model of prostate cancer
    Chakravarty, PK
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 154 - 154
  • [43] Provision of tumor-specific CD4+T cells to enhance tumor immunity in a murine model of prostate cancer
    Shafer-Weaver, Kimberly Ann
    Malyguine, Anatoli
    Hurwitz, Arthur A.
    FASEB JOURNAL, 2008, 22
  • [44] Characterizing tumor-specific memory stem like T cells in blood and bone marrow of breast cancer patients
    Pincha, Mudita
    Boonsawat, Paranchai
    Domschke, Christoph
    Beckhove, Philipp
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Induction of prostate specific membrane antigen (PSMA) on endothelial cells by incubation with tumor-conditioned medium of different ovarian cancer cell lines
    Persin, Sophia
    Jaeger, Markus
    Hertel, Felix
    Juhasz-Boess, Ingolf
    Unger, Clara
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 94 - 95
  • [46] Antigen Specific T-Cell Responses Against Tumor Antigens are Controlled by Regulatory T Cells in Patients With Prostate Cancer
    Hadaschik, Boris
    Su, Yun
    Huter, Eva
    Ge, Yingzi
    Hohenfellner, Markus
    Beckhove, Philipp
    JOURNAL OF UROLOGY, 2012, 187 (04): : 1458 - 1465
  • [47] A unique bioluminescent prostate cancer mouse model for the evaluation of stem-cell based gene therapy
    Suurbach, J. H.
    McGowan, E. M.
    Simpson, A.
    Tran, N.
    Martiniello-Wilks, R.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 288 - 288
  • [48] Engineering a Prostate-Specific Membrane Antigen-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy
    Denmeade, Samuel R.
    Mhaka, Annastasiah M.
    Rosen, D. Marc
    Brennen, W. Nathaniel
    Dalrymple, Susan
    Dach, Ingrid
    Olesen, Claus
    Gurel, Bora
    DeMarzo, Angelo M.
    Wilding, George
    Carducci, Michael A.
    Dionne, Craig A.
    Moller, Jesper V.
    Nissen, Poul
    Christensen, S. Brogger
    Isaacs, John T.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (140)
  • [49] Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management
    Goodman, Oscar
    Schuur, Eric R.
    CASE REPORTS IN ONCOLOGY, 2014, 7 (01): : 217 - 221
  • [50] Baseline and post-treatment circulating tumor cell (CTC) counts with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Sun, Michael
    Lebenthal, Justin M.
    Nauseef, Jones T.
    Niaz, Muhammad Junaid
    Guervil, Sabrina
    Fernandez, Escarleth
    Patel, Amie
    Tan, Angela
    Vlachostergios, Panagiotis J.
    Osborne, Joseph
    Molina, Ana M.
    Sternberg, Cora N.
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
12345